Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143)
Cat.#: ACPP-1143
Specifications
Despition Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence ADORA2A (Met1-Ser7) (Ser67-His Tag77) (Asn144-Pro173) (Cys259-Pro266) + hFc (Glu99-Ala330) Molecular Weight 31.7 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1225 POMT1 Blocking Peptide (AC1225) 250 µg inquiry ACPP-1836 Human CHGA Protein (AC1836) 5 µg inquiry ACPP-1839 Human Ornithine Aminotransferase Protein (AC1839) 5 µg inquiry ACPP-1382 Human EYA2 Protein (AC1382) 2 µg inquiry ACPP-1421 Human il-6 Protein, HEK (AC1421) 2 µg inquiry ACPP-1405 Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) 100 µg inquiry ACPP-1667 Human AGRP Protein (AC1667) 2 µg inquiry ACPP-1736 Human DYNLL1 Protein (AC1736) 5 µg inquiry ACPP-1106 Recombinant Human c-Kit Protein (6×His Tag) (AC1106) 50 µg inquiry ACPP-1280 SRPX2 Blocking Peptide (AC1280) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket